Mumbai, Maharashtra, India Unichem Laboratories Limited is pleased to announce that it has received ANDA approval from the United States Food and Drug Administration (U.S. FDA) for Metronidazole USP Tablets. Metronidazole USP Tablets 250mg and 500mg are therapeutically equivalent to Flagyl Tablets 250mg and 500mg of G.D Searle LLC. Metronidazole Tablet USP is an anti-infective agent used to treat a variety of bacterial and protozoal infections. The product will be commercialized from Unichem's Ghaziabad plant. Active pharmaceutical ingredient i.e., Metronidazole used for this ANDA is also made in house at Roha plant. Currently, around 6 other companies have generic approvals for the US market and the estimated market size is over US$ 100 Million. About Unichem Laboratories Limited. Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world. In India, the company is a leader in niche therapy areas of cardiology, neurology, orthopedics and anti-infectives. The company has strong skills in product development, process chemistry and manufacturing of complex API as well as dosage forms. More information about the company can be found at www.unichemlabs.com. Media Contact Details M Gundu Rao , Unichem Laboratories Limited , +91(22)66888380 , firstname.lastname@example.org K Subharaman , Unichem Laboratories Limited , +91(22)66888404 , email@example.com Rakesh Parikh , Unichem Laboratories Limited , +91(22)66888414 , firstname.lastname@example.org Monish Shah , Unichem Laboratories Limited , +91(22)66888509 , email@example.com Contributed via: Bloomberg Publisher WEB Service Provider ID: 7ecfda06a9a440a7809aad33e53c73ca -0- Jan/23/2014 12:50 GMT
Unichem Laboratories Receives ANDA Approval from USFDA for
Press spacebar to pause and continue. Press esc to stop.